Cargando…
Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and the 5-year cumulative incidence rate per 100,000 person...
Autores principales: | Ställberg, Björn, Janson, Christer, Lisspers, Karin, Johansson, Gunnar, Gutzwiller, Florian S., Mezzi, Karen, Bjerregaard, Bine Kjoeller, Kejs, Anne Mette Tranberg, Jorgensen, Leif, Larsson, Kjell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576803/ https://www.ncbi.nlm.nih.gov/pubmed/33082331 http://dx.doi.org/10.1038/s41533-020-00207-7 |
Ejemplares similares
-
The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study
por: Larsson, Kjell, et al.
Publicado: (2021) -
Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study
por: Lisspers, Karin, et al.
Publicado: (2019) -
Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
por: Larsson, Kjell, et al.
Publicado: (2022) -
Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β(2) agonist: observational matched cohort study (PATHOS)
por: Janson, Christer, et al.
Publicado: (2013) -
Economic burden of COPD in a Swedish cohort: the ARCTIC study
por: Lisspers, Karin, et al.
Publicado: (2018)